小方制药
(603207)
| 流通市值：11.71亿 | | | 总市值：47.01亿 |
| 流通股本：4000.00万 | | | 总股本：1.61亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 913,764,323.65 | 883,430,759.69 | 852,014,375.21 | 346,083,915.84 |
| 应收票据及应收账款 | 94,823,943.71 | 89,501,458.09 | 95,690,798.19 | 115,788,351.17 |
| 其中：应收票据 | 509,017.2 | 1,650,545.14 | 500,000 | - |
| 应收账款 | 94,314,926.51 | 87,850,912.95 | 95,190,798.19 | 115,788,351.17 |
| 应收款项融资 | 130,360.2 | 789,210.32 | - | - |
| 预付款项 | 6,995,325.49 | 10,797,878.16 | 7,490,535.46 | 7,066,205.24 |
| 其他应收款合计 | 477,035.01 | 548,968.11 | 663,259.88 | 599,880.37 |
| 存货 | 43,655,134.17 | 45,205,028.3 | 41,566,870.34 | 40,574,244.92 |
| 其他流动资产 | 2,753,276.77 | 1,661,067.24 | 1,359,059.32 | 15,293,825.69 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,062,599,399 | 1,031,934,369.91 | 998,784,898.4 | 525,406,423.23 |
| 非流动资产: | | | | |
| 固定资产 | 8,111,944.15 | 8,465,001.35 | 8,389,344.3 | 8,560,705.64 |
| 在建工程 | 332,311,598.06 | 329,169,035.8 | 312,681,593 | 269,034,490.72 |
| 使用权资产 | 302,955.86 | 403,941.14 | 504,926.42 | 605,911.69 |
| 无形资产 | 24,132,472.5 | 24,529,369.89 | 24,926,267.28 | 25,323,164.67 |
| 长期待摊费用 | 1,242,813.48 | 1,321,660.11 | 1,381,826.82 | 1,201,473.64 |
| 递延所得税资产 | 2,510,488.88 | 3,360,767.37 | 3,275,480.4 | 2,494,544.71 |
| 其他非流动资产 | 2,870,171.02 | 3,264,329.43 | 1,391,425 | 9,239,067.5 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 371,482,443.95 | 370,514,105.09 | 352,550,863.22 | 316,459,358.57 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,434,081,842.95 | 1,402,448,475 | 1,351,335,761.62 | 841,865,781.8 |
| 流动负债: | | | | |
| 短期借款 | 509,017.2 | 1,650,545.14 | - | - |
| 应付票据及应付账款 | 23,523,814.97 | 23,085,416.63 | 24,209,488.11 | 20,522,375.94 |
| 应付账款 | 23,523,814.97 | 23,085,416.63 | 24,209,488.11 | 20,522,375.94 |
| 合同负债 | 437,634.52 | 894,531.05 | 501,807.36 | 598,571.88 |
| 应付职工薪酬 | 6,141,561.46 | 6,201,511.32 | 5,985,192.62 | 5,630,639.91 |
| 应交税费 | 9,604,628.36 | 9,546,188.59 | 10,114,230.58 | 13,167,438.44 |
| 其他应付款合计 | 94,577,217.84 | 123,181,401.33 | 116,983,342.34 | 100,434,019.75 |
| 一年内到期的非流动负债 | 671,122.05 | 667,273.87 | 549,672.44 | 657,129.85 |
| 其他流动负债 | 4,383,412.76 | 2,921,568.02 | 2,375,903.13 | 1,393,939.39 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 139,848,409.16 | 168,148,435.95 | 160,719,636.58 | 142,404,115.16 |
| 非流动负债: | | | | |
| 租赁负债 | - | - | 112,499.99 | 223,702.36 |
| 递延收益 | 62,142.78 | 65,357.07 | 68,571.36 | 71,785.65 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 62,142.78 | 65,357.07 | 181,071.35 | 295,488.01 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 139,910,551.94 | 168,213,793.02 | 160,900,707.93 | 142,699,603.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,559,967 | 160,000,000 | 160,000,000 | 120,000,000 |
| 资本公积 | 486,145,666.4 | 478,228,980.55 | 478,030,960.45 | 69,615,641.87 |
| 减:库存股 | 8,382,705.99 | - | - | - |
| 盈余公积 | 63,143,455.25 | 63,143,455.25 | 42,617,733.85 | 42,617,733.85 |
| 未分配利润 | 592,704,908.35 | 532,862,246.18 | 509,786,359.39 | 466,932,802.91 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,294,171,291.01 | 1,234,234,681.98 | 1,190,435,053.69 | 699,166,178.63 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,294,171,291.01 | 1,234,234,681.98 | 1,190,435,053.69 | 699,166,178.63 |
| 负债和股东权益合计 | 1,434,081,842.95 | 1,402,448,475 | 1,351,335,761.62 | 841,865,781.8 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-29 | 2024-08-07 |
| 审计意见(境内) | | 标准无保留意见 | | |